These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 681701)

  • 41. [Contraception using normal dose progestins].
    Pelissier-langbort C
    Contracept Fertil Sex (Paris); 1984 Oct; 12(10):1099-109. PubMed ID: 12266559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of infecundin in dyshormonal hyperplasia of the breast associated with ovarian dysfunction].
    Mezinova NN
    Sov Med; 1975 Jun; (6):85-90. PubMed ID: 1162479
    [No Abstract]   [Full Text] [Related]  

  • 44. [Why should benign mastopathies be treated medically?].
    Mauvais-Jarvis P
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):623-6. PubMed ID: 4067217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormone replacement therapy and risk of breast cancer: the role of progestins.
    Stahlberg C; Pedersen AT; Lynge E; Ottesen B
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):335-44. PubMed ID: 12716318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of progesterone and progestational hormones on the mammary gland].
    Gorins A; Denis C
    Arch Anat Cytol Pathol; 1995; 43(1-2):28-35. PubMed ID: 7794024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous progesterone use and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease.
    Plu-Bureau G; Lê MG; Thalabard JC; Sitruk-Ware R; Mauvais-Jarvis P
    Cancer Detect Prev; 1999; 23(4):290-6. PubMed ID: 10403900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of norsteroid treatment on the histologic structure of mastopathic breast tissue (author's transl)].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kádas I; Rákócszi I
    Arch Geschwulstforsch; 1973; 41(4):359-62. PubMed ID: 4355777
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind controlled trial of progesterone vaginal cream treatment for cyclical mastodynia in women with benign breast disease.
    Nappi C; Affinito P; Di Carlo C; Esposito G; Montemagno U
    J Endocrinol Invest; 1992 Dec; 15(11):801-6. PubMed ID: 1291593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease.
    Uzan S; Denis C; Pomi V; Varin C
    Eur J Obstet Gynecol Reprod Biol; 1992 Feb; 43(3):219-27. PubMed ID: 1563574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclic progestin therapy for the management of mastopathy and mastodynia.
    Winkler UH; Schindler AE; Brinkmann US; Ebert C; Oberhoff C
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():37-43. PubMed ID: 12227885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progestinic treatment of mastodynia. New suggestion for the follow-up.
    Onnis A; Nardelli GB; Mozzanega B; Lamaina V; Onnis GL; Maggino T; Litta P; Marchetti M
    Eur J Gynaecol Oncol; 1984; 5(1):11-5. PubMed ID: 6698048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Psychophysiological aspects of mastalgia. Psychometric studies (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1978 Jun; 120(24):835-8. PubMed ID: 307154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aetiology, diagnosis und therapy of mastopathy and mastodynia. Experiences of treatment with mastodynon (author's transl)].
    Fikentscher H
    Med Klin; 1977 Aug; 72(34):1327-30. PubMed ID: 895654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progesterone cream for cyclic breast pain.
    McFadyen IJ; Raab GM; Macintyre CC; Forrest AP
    BMJ; 1989 Apr; 298(6678):931. PubMed ID: 2497864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.